AI assistant
Sending…
Sana Biotechnology, Inc. — Director's Dealing 2021
Feb 4, 2021
32303_dirs_2021-02-03_6f46a44b-c9a9-4d9c-a116-2c889d82fefd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Sana Biotechnology, Inc. (SANA)
CIK: 0001770121
Period of Report: 2021-02-03
Reporting Person: REICIN ALISE (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.80 | 2030-12-07 | Common Stock (93750) | Direct |
Footnotes
F1: The option vests and becomes exercisable as to 25% of the underlying shares on December 4, 2021 and in 36 equal monthly installments thereafter.
More from Sana Biotechnology, Inc.
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
May 15
Share Issue/Capital Change
2026
May 11
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Board/Management Information
2026
Apr 24
Capital/Financing Update
2026
Apr 13
Regulatory Filings
2026
Apr 13
Director's Dealing
2026
Mar 4
Capital/Financing Update
2026
Mar 3